BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3357653)

  • 21. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
    Shulman LP; Yankov V; Uhl K
    Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
    Rungruxsirivorn T; Panyakamlerd K; Trerattanachart S; Taechakraichana N
    J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE; Koltun WD; Pascual ML; Day WW; Peterson C
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR; Ettinger B; Macer JL; Ensrud KE; Quan J; Grady D
    Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
    Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS; Rebar RW; Cuffie-Jackson C; Cedars MI; Lobo RA; Shoupe D; Judd HL; Buyalos RP; Clisham PR
    Maturitas; 2004 Oct; 49(2):140-7. PubMed ID: 15474758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen replacement therapy by transdermal estradiol administration.
    Laufer LR; DeFazio JL; Lu JK; Meldrum DR; Eggena P; Sambhi MP; Hershman JM; Judd HL
    Am J Obstet Gynecol; 1983 Jul; 146(5):533-40. PubMed ID: 6407324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
    Guthrie JR; Dennerstein L; Hopper JL; Burger HG
    Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
    Sajtos B; Herold J; Winkler UH; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of estradiol from two transdermal patches.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Mar; 46(3):307-10. PubMed ID: 8901155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Marini H; Atteritano M; Cancellieri F; Corrado F; Triolo O; Rizzo P; Russo S; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Adamo EB; Squadrito F
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD; Ehrly AM; Kuhl H
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.